139 related articles for article (PubMed ID: 31005205)
1. MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.
Owczarczyk K; Prezzi D; Cascino M; Kozarski R; Gaya A; Siddique M; Cook GJ; Glynne-Jones R; Goh V
Radiother Oncol; 2019 May; 134():119-126. PubMed ID: 31005205
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
[TBL] [Abstract][Full Text] [Related]
3. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.
Muirhead R; Bulte D; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Virdee PS; Qi C; Hawkins MA
Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):874-883. PubMed ID: 33023818
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
9. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
10. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
11. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
12. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
14. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
15. The role of MRI in the assessment of the local status of anal carcinomas and in their management.
Jederán É; Lővey J; Szentirmai Z; Hitre E; Léránt G; Horváth K; Gődény M
Pathol Oncol Res; 2015 Jul; 21(3):571-9. PubMed ID: 25354914
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
17. Current therapeutic strategies for anal squamous cell carcinoma in Japan.
Takashima A; Shimada Y; Hamaguchi T; Ito Y; Masaki T; Yamaguchi S; Kondo Y; Saito N; Kato T; Ohue M; Higashino M; Moriya Y;
Int J Clin Oncol; 2009 Oct; 14(5):416-20. PubMed ID: 19856049
[TBL] [Abstract][Full Text] [Related]
18. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
19. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy.
Jones M; Hruby G; Stanwell P; Gallagher S; Wong K; Arm J; Martin J
BMC Cancer; 2015 Apr; 15():281. PubMed ID: 25885556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
